Cancer treatment has long been haunted by the same problem: how do you strike dangerous cells without hitting healthy ones ...

A lymph node–targeted delivery platform releases antibody therapy only in tumor-like conditions, strengthening immune attack ...

A cancer drug target already being investigated in clinical trials turns out to be doing something even more consequential ...

Cancer cells may be exploiting a common antioxidant as fuel, revealing a potential weakness that future therapies could ...

Super-enhancers (SEs) are large clusters of transcriptional regulatory elements that drive oncogene expression, maintain ...

Cells aren’t as passive as scientists once thought—they actively create internal currents to move proteins quickly and ...

Researchers at the University of Geneva have built a molecular system that can tell the difference between a cancer cell and ...

Researchers have successfully used repurposed cancer drugs to target dormant breast cancer cells, aiding in the delay or prevention of recurrence, according to a study published Sept. 2 in Nature ...

Lung cancer is the second-most common cancer and the leading cause of cancer death in the United States. Over 80% of lung cancers are non-small cell lung cancers, in which tumor cells are larger and ...

University of Mississippi research offers hope that cancer drug therapies packaged in 3D-printed carriers could deliver ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Cystic adenocarcinoma (marked in red) of the pancreas (outlined in green). Contrast‑enhanced ...